Addressing drug shortages requires the industry to embrace innovative advanced manufacturing processes underpinned by ...

The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day ...

Bruce Leuchter, CEO, Neurvati, discusses the indispensable role of patient advocates—particularly in rare and serious disease drug development—in shaping trial design, site selection, and regulatory ...

In an interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, explained how AI can help address clinical trial diversity and access challenges by reducing physician workload ...

In a recent interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, discussed how AI is transforming clinical trials by reducing costs, accelerating timelines, and enhancing ...

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National ...

In the first part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

Ruth Beadle, head, global supply chain, Sanofi, discusses how digital integration, advanced planning, and sustainability goals are transforming end-to-end supply chain operations to improve scale, ...

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while ...